Harnessing analytical tool innovation for R&D, product characterization, and QC
Nucleic Acid Insights 2026; 3(5), 361–364
DOI: 10.18609/nai.2026.043
Published: 29 June
Foreword
Jeske Smink
“As RNA therapeutics continue their journey from niche technologies to mainstream medicines ... it has become a strategic enabler of innovation, manufacturability and regulatory confidence.